The CIA gathers industry insights through a quarterly business survey to advocate for our members’ interests with policy makers, regulators and other stakeholders.
Read more
The CIA is proud to announce the launch of the new Sustainable Health Metrics Tool.
Read more
The chemical and pharmaceutical industry is fundamental to modern society. With an immense variety of products, from vital medicines and foods, the construction of buildings, to transport and leisure, the industry truly does have an impact on virtually every aspect of our daily lives.
Read moreThe reappearance of an industrial strategy after a six-year absence is a welcome and long-overdue step. The detail needs scrutinising, especially on energy but now we have something, let growth be incentivised and see if we can rescue at least some of the 200,000 job losses that have happened in the period without one.
In a major step forward, following our engagement with Government we are pleased to see that chemicals have been recognised in the industrial strategy to be “at the core of Advanced Manufacturing underpinning all domestic manufacturing.”
On driving down energy costs, Government has today taken a step forward in reducing energy costs opposite those faced by our competitors. The commitment to strengthen and retain the British Supercharger package for our most energy intensive business, alongside the inclusion of chemical businesses under the newly announced British Industrial Competitiveness Scheme sends the right signal. Whilst there is much more to do and details of the scheme will be key in determining whether they boost industrial competitiveness, we will be working hard to ensure all chemical businesses can benefit from the interventions announced today.
We encourage Government to continue to engage with us in constructive dialogue to ensure that this strategy translates into real world competitiveness, sustainable growth and a renewed role for UK chemical manufacturing as an engine of economic resilience.
Figures released by the CIA indicate sustained growth for Q2 2024, building on the positive performance seen in the first three months of the year. This marks a significant recovery following 18 months of severe decline.
